[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"gastric-motility-disorder\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:gastric-motility-disorder":28},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":15,"eligibilityCriteria":16,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":19,"enrollmentInfo":20,"targetDuration":4,"studyType":23,"phases":4,"briefSummary":24,"conditions":25,"keywords":29,"overallStatus":42,"whyStopped":4,"lastUpdateSubmitDate":43,"lastUpdatePostDateStruct":44,"startDateStruct":47,"completionDateStruct":49,"leadSponsor":51,"locationsCount":54},"100456887","study-of-gastric-motility-in-eosinophilic-gastritis-100456887",false,"NCT05229432","Study of Gastric Motility in Eosinophilic Gastritis","Pilot Assessment to Find Evidence of Gastric Motility Abnormalities in Eosinophilic Gastric Disorders","OAT-FEED","Inclusion Criteria:\n\n* Eosinophilic gastritis (EG) defined as at least one endoscopy with histopathologic evidence of ≥ 30 eosinophils in 5 or more high powered fields (hpf's) with associated symptoms of EG.\n* Patient reported symptoms starting at least one year or more prior to screening consistent with a diagnosis of EG: nausea, vomiting, early satiety, abdominal pain\u002Fbloating, regurgitation, diarrhea.\n* Symptoms suggestive of a possible gastric motility disorder during the 60 days prior to screening including: nausea, vomiting, early satiety, post-prandial feeling of fullness or bloating.\n* Tolerance and willingness to consume the oatmeal meal in this study.\n\nExclusion Criteria:\n\n* Diagnosis of eosinophilic enteritis.\n* Inflammatory bowel disease (e.g., Crohn's disease or ulcerative colitis).\n* Known disorders associated with eosinophilic gastrointestinal (GI) diseases (e.g., D 816 V Kit+ systemic mastocytosis, Marfan syndrome or Loey's Dietz Syndrome).\n* Known inflammatory or autoimmune disorders associated with gastric dysmotility such as systemic sclerosis, lupus or eosinophilic fasciitis.\n* Uncontrolled diabetes or known diabetic complications of gastroparesis, neuropathy or nephropathy.\n* Taking opioid agents in the 2 weeks prior to screening and throughout the study.\n* History of strictures in the small bowel or stomach (e.g., pyloric stenosis) or gastric surgeries or procedures such as pyloromyotomy, pyloric dilation, pyloric resection, vagotomy, bariatric surgery or post-Nissen fundoplication or antrectomy with Billroth I, Billroth II or Roux-en-Y gastrojejunostomy.\n* Past or current medical problems or findings such as: advanced liver disease (Child's B or C), acute or chronic renal disease (serum creatinine \\> 3 mg\u002FdL), neurologic disease (e.g., dysautonomia), achalasia and adrenal insufficiency.","ALL","18 Years","59 Years",{"count":21,"type":22},30,"ESTIMATED","OBSERVATIONAL","Purpose:\n\nThe study is a cross-sectional observational study designed to determine if eosinophilic gastritis (EG) results in gastric motility impairment.\n\nHypothesis:\n\nGastric dysfunction occurs in the natural history of EG but is underdiagnosed due, in part, to contraindications to the use of the standard meals used in gastric emptying studies.",[26,27,28],"Eosinophilic Gastritis","Gastroparesis","Gastric Motility Disorder",[30,31,32,33,34,35,36,37,38,39,40,41],"Gastritis","Eosinophilic Gastrointestinal Disorders","Gastric Dysfunction","Gastric Dysmotility","Eosinophils","Eosinophilia","Eosinophilic Disorders","Digestive System Diseases","Immune System Diseases","Stomach Diseases","Gastric Emptying Scintigraphy","Endoscopy","RECRUITING","2026-03-26",{"date":45,"type":46},"2026-03-31","ACTUAL",{"date":48,"type":46},"2023-01-25",{"date":50,"type":22},"2026-12-01",{"name":52,"class":53},"Children's Hospital Medical Center, Cincinnati","OTHER",3]